Home ➤ Life Science ➤ Medical Devices & Supplies ➤ Transdermal Patch Market
Transdermal Patch Market
Published date: Feb 2024 • Formats:
Request Sample Schedule a Call

Global Transdermal Patch Market By Type (Drug-in-Adhesive, Matrix and Other Types) By Application (Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy and Other Applications) By End Use (Homecare Setting, Hospitals and Clinics) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033

  • Published date: Feb 2024
  • Report ID: 15591
  • Number of Pages: 299
  • Format:
  • keyboard_arrow_up
    • 1. Transdermal Patch Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Transdermal Patch Market Overview
      • 3.1. Transdermal Patch Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Transdermal Patch Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Transdermal Patch Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Fentanyl Transdermal Patch
      • 4.4. Nicotine Transdermal Patch
      • 4.5. Buprenorphine Transdermal Patch
      • 4.6. Clonidine Transdermal Patch
      • 4.7. Oxybutynin Transdermal Patch
    • 5. Global Transdermal Patch Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Transdermal Patch Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
      • 5.4. Nicotine skin patches are used to help people stop smoking cigarettes.
      • They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.
      • 5.5. ApplictionC
      • 5.6. ApplictionD
      • 5.7. ApplictionE
    • 6. Global Transdermal Patch Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Transdermal Patch Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2. Europe
        • 6.2.1. Europe Transdermal Patch Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Transdermal Patch Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Transdermal Patch Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Transdermal Patch Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Transdermal Patch Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Hisamitsu Pharmaceutical
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Novartis
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Johnson & Johnson
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Teikoku Pharma
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Mylan
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Actavis
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Mundipharma
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. Henan Lingrui Pharmaceutical
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. Changzhou Siyao
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. Rfl Pharmaceutical
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
    • Hisamitsu Pharmaceutical
    • Novartis AG Company Profile
    • Johnson & Johnson
    • Teikoku Pharma
    • Mylan
    • Actavis
    • Mundipharma
    • Henan Lingrui Pharmaceutical
    • Changzhou Siyao
    • Rfl Pharmaceutical
    • AdhexPharma
    • ProSolus, Inc
    • Tapemark
    • Tesa Tapes (India) Pvt. Ltd.
    • Nitto Denko Corporation.
    • Noven Pharmaceuticals, Inc
    • LTS Lohmann Therapie-Systeme AG
    • Medherant Limited
    • Corium, Inc.
    • Bayer AG Company Profile
    • Other Key Players
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Transdermal Patch Market
  • 15591
  • Feb 2024
    • ★★★★★
      ★★★★★
    • (57)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
 Multi User
$8,000
$5,999
USD / per unit
save 28%
 Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999)Buy Now ($ 5,999)Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options